Antisense RNA complementary to hepatitis B virus specifically inhibits viral replication (Q41012434)

25 September 2017

title

Antisense RNA complementary to hepatitis B virus specifically inhibits viral replication (English)

1 reference

25 September 2017

1 reference

zu Putlitz J

1

1 reference

25 September 2017

Wieland S

series ordinal

2

1 reference

25 September 2017

Blum HE

series ordinal

3

1 reference

25 September 2017

Wands JR

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

25 September 2017

1 reference

25 September 2017

volume

115

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

702-713

1 reference

Inhibition of hepatitis B virus by antisense oligodeoxynucleotides

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

CpG motifs in bacterial DNA trigger direct B-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

M13 bacteriophage DNA inhibits duck hepatitis B virus during acute infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Inhibition of thymidine kinase gene expression by anti-sense RNA: A molecular approach to genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Measles virus antisense sequences specifically cure cells persistently infected with measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Permanent inhibition of angiotensinogen synthesis by antisense RNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Gene therapy. Intracellular immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

A novel expression assay to study transcriptional activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Complete nucleotide sequence of the rabbit beta-like globin gene cluster. Analysis of intergenic sequences and comparison with the human beta-like globin gene cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Human non-hepatocytes support hepadnaviral replication and virion production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

High-efficiency transformation of mammalian cells by plasmid DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Human growth hormone as a reporter gene in regulation studies employing transient gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Quantitative evaluation of intracellular sense: antisense RNA hybrid duplexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Inhibition of hepatitis B virus by retroviral vectors expressing antisense RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Engineering of the mRNA-interfering complementary RNA immune system against viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Inhibition of retroviral replication by anti-sense RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Genetically engineered resistance to dengue-2 virus transmission in mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

A hitchhiker's guide to antisense and nonantisense biochemical pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

What makes an mRNA anti-sense-itive?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Injected anti-sense RNAs specifically block messenger RNA translation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

The conditional inhibition of gene expression in cultured Drosophila cells by antisense RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

RNase III cleaves eukaryotic preribosomal RNA at a U3 snoRNP-dependent site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

A developmentally regulated activity that unwinds RNA duplexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Interferon-induced enzymatic activities and their role in the antiviral state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

PKR: a new name and new roles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Activation of interferon-inducible 2'-5' oligoadenylate synthetase by adenoviral VAI RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Theoretical and experimental selection parameters for HBV-directed antisense RNA are related to increased RNA-RNA annealing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

Expression of functional hepatitis B virus polymerase in yeast reveals it to be the sole viral protein required for correct initiation of reverse transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

7 January 2021

Antisense RNA and DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

7 January 2021

Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

7 January 2021

The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

7 January 2021

Novel mechanism for reverse transcription in hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970150-7

7 January 2021

10.1016/S0016-5085(98)70150-7

Identifiers

DOI

1 reference

25 September 2017

1 reference